YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
NCT01028950
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Venous Thromboembolism
Interventions
DRUG:
YM150
Sponsor
Astellas Pharma Inc